176 related articles for article (PubMed ID: 15487693)
21. Intravitreal triamcinolone as adjunctive treatment to laser panretinal photocoagulation for concomitant proliferative diabetic retinopathy and clinically significant macular oedema.
Margolis R; Singh RP; Bhatnagar P; Kaiser PK
Acta Ophthalmol; 2008 Feb; 86(1):105-10. PubMed ID: 17608830
[TBL] [Abstract][Full Text] [Related]
22. Visual Field Changes Over 5 Years in Patients Treated With Panretinal Photocoagulation or Ranibizumab for Proliferative Diabetic Retinopathy.
Maguire MG; Liu D; Glassman AR; Jampol LM; Johnson CA; Baker CW; Bressler NM; Gardner TW; Pieramici D; Stockdale CR; Sun JK;
JAMA Ophthalmol; 2020 Mar; 138(3):285-293. PubMed ID: 31999300
[TBL] [Abstract][Full Text] [Related]
23. Patient Comfort with Yellow (577 nm) vs. Green (532 nm) Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy.
Adam MK; Weinstock BM; Kasi SK; Ehmann DS; Hsu J; Garg SJ; Ho AC; Chiang A
Ophthalmol Retina; 2018 Feb; 2(2):91-95. PubMed ID: 31047351
[TBL] [Abstract][Full Text] [Related]
24. Panretinal laser photocoagulation for proliferative diabetic retinopathy: the effect of laser wavelength on macular function.
Canning C; Polkinghorne P; Ariffin A; Gregor Z
Br J Ophthalmol; 1991 Oct; 75(10):608-10. PubMed ID: 1954210
[TBL] [Abstract][Full Text] [Related]
25. Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: full- versus mild-scatter coagulation.
Pahor D
Int Ophthalmol; 1998; 22(5):313-9. PubMed ID: 10826550
[TBL] [Abstract][Full Text] [Related]
26. [A grid pattern type of photocoagulation in treatment of diabetic maculopathy--personal experience].
Romaniuk W; Kozioł H; Markowska J; Fronczek M; Klimek J; Strojek K
Klin Oczna; 2000; 102(3):183-6. PubMed ID: 11126173
[TBL] [Abstract][Full Text] [Related]
27. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
[TBL] [Abstract][Full Text] [Related]
28. PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Should Baseline Characteristics Affect Choice of Treatment?
Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
Retina; 2019 Sep; 39(9):1646-1654. PubMed ID: 30807516
[TBL] [Abstract][Full Text] [Related]
29. One-year outcomes of panretinal photocoagulation in proliferative diabetic retinopathy.
Kaiser RS; Maguire MG; Grunwald JE; Lieb D; Jani B; Brucker AJ; Maguire AM; Ho AC; Fine SL
Am J Ophthalmol; 2000 Feb; 129(2):178-85. PubMed ID: 10682970
[TBL] [Abstract][Full Text] [Related]
30. CHOROIDAL THICKNESS CHANGES IN PROLIFERATIVE DIABETIC RETINOPATHY TREATED WITH PANRETINAL PHOTOCOAGULATION VERSUS PANRETINAL PHOTOCOAGULATION WITH INTRAVITREAL BEVACIZUMAB.
Roohipoor R; Sharifian E; Ghassemi F; Riazi-Esfahani M; Karkhaneh R; Fard MA; Zarei M; Modjtahedi BS; Moghimi S
Retina; 2016 Oct; 36(10):1997-2005. PubMed ID: 27046456
[TBL] [Abstract][Full Text] [Related]
31. Retinal vessel analyzer measurements of the effect of panretinal photocoagulation on the retinal arteriolar diameter in diabetic retinopathy.
Mendrinos E; Mangioris G; Papadopoulou DN; Dosso AA; Pournaras CJ
Retina; 2010 Apr; 30(4):555-61. PubMed ID: 20010452
[TBL] [Abstract][Full Text] [Related]
32. Panretinal photocoagulation (PRP) versus PRP plus intravitreal ranibizumab for high-risk proliferative diabetic retinopathy.
Filho JA; Messias A; Almeida FP; Ribeiro JA; Costa RA; Scott IU; Jorge R
Acta Ophthalmol; 2011 Nov; 89(7):e567-72. PubMed ID: 21726427
[TBL] [Abstract][Full Text] [Related]
33. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study.
Muqit MM; Young LB; McKenzie R; John B; Marcellino GR; Henson DB; Turner GS; Stanga PE
Br J Ophthalmol; 2013 Feb; 97(2):220-7. PubMed ID: 23178855
[TBL] [Abstract][Full Text] [Related]
34. Panretinal photocoagulation and intravitreal triamcinolone acetonide for the management of proliferative diabetic retinopathy with macular edema.
Zein WM; Noureddin BN; Jurdi FA; Schakal A; Bashshur ZF
Retina; 2006 Feb; 26(2):137-42. PubMed ID: 16467667
[TBL] [Abstract][Full Text] [Related]
35. Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy.
Lee CM; Olk RJ; Akduman L
Ophthalmic Surg Lasers; 2000; 31(4):292-300. PubMed ID: 10928666
[TBL] [Abstract][Full Text] [Related]
36. Effect of panretinal photocoagulation on choroidal circulation in the foveal region in patients with severe diabetic retinopathy.
Takahashi A; Nagaoka T; Sato E; Yoshida A
Br J Ophthalmol; 2008 Oct; 92(10):1369-73. PubMed ID: 18662912
[TBL] [Abstract][Full Text] [Related]
37. Reading deficits in diabetic patients treated with panretinal photocoagulation and good visual acuity.
Omari A; Niziol LM; Gardner TW
Acta Ophthalmol; 2019 Nov; 97(7):e1013-e1018. PubMed ID: 30968579
[TBL] [Abstract][Full Text] [Related]
38. Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: a randomized study in 44 eyes with a long follow-up time.
Bandello F; Brancato R; Trabucchi G; Lattanzio R; Malegori A
Graefes Arch Clin Exp Ophthalmol; 1993 Sep; 231(9):491-4. PubMed ID: 8224951
[TBL] [Abstract][Full Text] [Related]
39. Subthreshold diode micropulse panretinal photocoagulation for proliferative diabetic retinopathy.
Luttrull JK; Musch DC; Spink CA
Eye (Lond); 2008 May; 22(5):607-12. PubMed ID: 17293791
[TBL] [Abstract][Full Text] [Related]
40. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision.
Shimura M; Yasuda K; Nakazawa T; Kano T; Ohta S; Tamai M
Ophthalmology; 2003 Dec; 110(12):2386-94. PubMed ID: 14644723
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
